ITI Pharma and Healthcare Fund - Direct - Growth

Equity Scheme by ITI Asset Management Limited

3Y Returns (CAGR)
18.56%
Expense Ratio
0.92%

as of 01/08/2026

AUM
₹18.82 Cr

Qtr End: Jun 26

NAV
₹18.784

as of 16/10/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M-3.23%-12.32%13.10%
6M11.13%23.49%12.98%
1Y4.61%4.61%13.69%
3Y66.64%18.56%14.39%
5Y87.37%13.38%13.61%
Scheme Details
Launch Date
18/10/2021
Fund Age
5 years
Minimum Investment
₹5,000
Fund House
ITI Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions